loadpatents
name:-0.058024168014526
name:-0.011718988418579
name:-0.006476879119873
YLA-HERTTUALA; Seppo Patent Filings

YLA-HERTTUALA; Seppo

Patent Applications and Registrations

Patent applications and USPTO patent grants for YLA-HERTTUALA; Seppo.The latest application filed is for "synthetic microrna mimics".

Company Profile
4.11.57
  • YLA-HERTTUALA; Seppo - Kuopio FI
  • Yla-Herttuala; Seppo - Helsinki FI
  • Yla-Herttuala; Seppo - Vuorela FI
  • Yla-Herttuala, Seppo - Vuovela FI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Synthetic Microrna Mimics
App 20220186228 - TURUNEN; Mikko Petri ;   et al.
2022-06-16
Fixed-bed bioreactor with constant-flow pump / tubing system
Grant 11,261,416 - Valonen , et al. March 1, 2
2022-03-01
Aseptic bioreactor sampling system
Grant 11,242,504 - Valonen , et al. February 8, 2
2022-02-08
Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
App 20200354409 - TURKKI; Vesa ;   et al.
2020-11-12
Nucleic acid application primers
Grant 10,829,785 - Lesch , et al. November 10, 2
2020-11-10
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
App 20200222477 - PARKER; Nigel ;   et al.
2020-07-16
Transgene-Cytotoxic Combination Therapy
App 20200101100 - SAMARANAYAKE; Haritha ;   et al.
2020-04-02
Nucleic Acid Application Primers
App 20200071725 - Lesch; Hanna P. ;   et al.
2020-03-05
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
App 20190276846 - LIPPONEN; Eevi ;   et al.
2019-09-12
Anti-Angiogenic Gene Therapy Kit
App 20190275106 - YLA-HERTTUALA; Seppo ;   et al.
2019-09-12
Combination Therapy For Cancer
App 20170348345 - SAMARANAYAKE; Haritha ;   et al.
2017-12-07
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
App 20170051309 - LESCH; Hanna P. ;   et al.
2017-02-23
Production of Lentiviral Vectors
App 20170016028 - YLA-HERTTUALA; Seppo ;   et al.
2017-01-19
Production of Vectors for Non-Dividing Host Cells
App 20160097060 - LESCH; Hanna P. ;   et al.
2016-04-07
Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
App 20160058888 - Yla-Herttuala; Seppo
2016-03-03
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
App 20140057851 - YLA-HERTTUALA; Seppo
2014-02-27
Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity
App 20140017204 - PARKER; Nigel ;   et al.
2014-01-16
Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity
App 20140017202 - PARKER; Nigel ;   et al.
2014-01-16
Combination Therapy for Cancer
App 20130331442 - SAMARANAYAKE; Haritha ;   et al.
2013-12-12
Combination Therapy for Cancer
App 20130310444 - Samaranayake; Haritha ;   et al.
2013-11-21
Combination Therapy for Cancer
App 20130296407 - SAMARANAYAKE; Haritha ;   et al.
2013-11-07
Use of VEGF-D gene to prevent restenosis
Grant 8,455,453 - Alitalo , et al. June 4, 2
2013-06-04
Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
App 20120308522 - MARTIN; John Francis ;   et al.
2012-12-06
VEGF-D mutants and their use
Grant 8,188,039 - Toivanen , et al. May 29, 2
2012-05-29
Modified Vegf-a With Improved Angiogenic Properties
App 20120071406 - ALITALO; KARI ;   et al.
2012-03-22
Modified VEGF-A with improved angiogenic properties
Grant 8,025,886 - Alitalo , et al. September 27, 2
2011-09-27
VEGF-D Mutants and Their Use
App 20110144013 - Toivanen; Pyry ;   et al.
2011-06-16
Non-Aggregating Virus Formulation
App 20110052540 - Shaw; Robert ;   et al.
2011-03-03
Method for Incorporating Proteins Into Lentivirus Vectors
App 20100221791 - Schenkwein; Diana ;   et al.
2010-09-02
Use of VEGF-C or VEGF-D in Reconstructive Surgery
App 20100041605 - Alitalo; Kari ;   et al.
2010-02-18
Production of Lentiviral Vectors
App 20100003746 - Lesch; Hanna P. ;   et al.
2010-01-07
Engineered Baculoviruses and Their Use
App 20090176660 - Yla-Herttuala; Seppo ;   et al.
2009-07-09
Avidin-Pseudotyped Viral Vectors and Their Use
App 20090047733 - Airenne; Kari Juhani ;   et al.
2009-02-19
Integrase Fusion Proteins And Their Use With Integrating Gene Therapy
App 20090011509 - Ahlroth; Mervi ;   et al.
2009-01-08
Biotin-binding receptor molecules
App 20090011984 - Yla-Herttuala; Seppo ;   et al.
2009-01-08
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
App 20080305999 - Martin; John Francis ;   et al.
2008-12-11
Pseudotyped Baculovirus and its Use
App 20080280363 - Airenne; Kari Juhani ;   et al.
2008-11-13
Baculovirus-Based Gene Libraries
App 20080280783 - Airenne; Kari Juhani ;   et al.
2008-11-13
Peptides and their use in assays for cardiovascular disease
App 20080261234 - Narvanen; Outi ;   et al.
2008-10-23
Avidin-pseudotyped viral vectors and their use
Grant 7,393,677 - Airenne , et al. July 1, 2
2008-07-01
Use of VEGF-C or VEGF-D in Reconstructive Surgery
App 20080147045 - Alitalo; Kari ;   et al.
2008-06-19
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
Grant 7,320,679 - Martin , et al. January 22, 2
2008-01-22
Expression Cassette
App 20070224675 - Airenne; Kari Juhani ;   et al.
2007-09-27
Modified VEGF-A with improved angiogenic properties
App 20070142282 - Alitalo; Kari ;   et al.
2007-06-21
Nucleic acids encoding biotin-binding receptors
Grant 7,208,291 - Yla-Herttuala , et al. April 24, 2
2007-04-24
Avidin-pseudotyped viral vectors and their use
App 20060246091 - Airenne; Kari Juhani ;   et al.
2006-11-02
Periadventitial delivery device
App 20060093653 - Martin; John Francis ;   et al.
2006-05-04
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
App 20050256075 - Alitalo, Kari ;   et al.
2005-11-17
Use of VEGF-C to prevent restenosis
Grant 6,958,147 - Alitalo , et al. October 25, 2
2005-10-25
Engineered baculoviruses and their use
App 20050201983 - Yla-Herttuala, Seppo ;   et al.
2005-09-15
Use of VEGF-C or VEGF-D in reconstructive surgery
App 20050043235 - Alitalo, Kari ;   et al.
2005-02-24
Medical device
App 20050002981 - Lahtinen, Mika ;   et al.
2005-01-06
VEGF-B and PDGF modulation of stem cells
App 20040248796 - Alitalo, Kari ;   et al.
2004-12-09
Gene delivery of a viral vector
App 20040208905 - Yla-Herttuala, Seppo ;   et al.
2004-10-21
Biotin-binding receptor molecules
App 20040185059 - Yla-Herttuala, Seppo ;   et al.
2004-09-23
Avidin pseudotyped viral vectors and their use
App 20040146487 - Airenne, Kari Juhani ;   et al.
2004-07-29
Peptides and their use in assays for cardiovascular disease
App 20040091934 - Narvanen, Outi ;   et al.
2004-05-13
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
App 20030225020 - Martin, John Francis ;   et al.
2003-12-04
Combination for the treatment of endothelial damage
App 20030099687 - Alitalo, Kari ;   et al.
2003-05-29
Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
App 20030064954 - Urtti, Arto ;   et al.
2003-04-03
Periadventitial delivery device
App 20030039694 - Martin, John Francis ;   et al.
2003-02-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed